On Feb. 24, the Drug Enforcement Administration (DEA) issued proposals to make permanent limited flexibilities for prescribing controlled substances via telehealth. One proposal covers situations when telehealth is used to prescribe controlled substances when the practitioner and the patient do not have a prior in-person medical evaluation. The DEA is also amending its regulations to expand the circumstances under which individual practitioners are authorized to prescribe schedule III-V narcotic drugs or combinations of such drugs approved for use in continuous medical treatment or withdrawal management treatment via a telehealth encounter.
Click here for the DEA announcement about the rules, which provides links to additional materials and information.
